Alberto Ferlin
Alberto Ferlin is an expert in Endocrinology at Azienda Ospedaliera di Padova (Italy). As of October 2026, ScienceLeadR ranks Alberto Ferlin in the top 1% of experts worldwide for Oligospermia, Azoospermia and Infertility. Alberto Ferlin has authored 418 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,402 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Genetics - Biochemistry - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 418
Citations
Main journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Waist circumference outperforms cardiometabolic indices for identifying hypogonadism in Klinefelter Syndrome. PMID 42875728 — hypogonadism, testosterone, klinefelter syndrome, waist circumference | J Clin Endocrinol Metab | 2026 | 0 |
| Managing growth and puberty concerns in individuals with Duchenne muscular dystrophy: Updated guidance and future directions. PMID 42857968 — glucocorticoids, hypogonadism, fertility, growth, muscular dystrophies, puberty, muscular dystrophy, duchenne, testosterone, neuromuscular diseases, research, steroids | J Neuromuscul Dis | 2026 | 0 |
| Adrenal insufficiency in individuals with Duchenne muscular dystrophy treated with glucocorticoids: Insights from the past, current challenges, and future directions. PMID 42770351 — glucocorticoids, adrenal insufficiency, muscular dystrophies, muscular dystrophy, duchenne, therapeutics | J Neuromuscul Dis | 2026 | 0 |
| Preimplantation genetic testing for male factor infertility: lights and shadows. PMID 42606815 — endocrinology, research design, genetic testing, infertility, aneuploidy, spermatozoa | J Endocrinol Invest | 2026 | 0 |
| Risk and management of congenital thrombophilia in transgender individuals undergoing gender-affirming hormone therapy. PMID 42517015 — antibodies, antiphospholipid, antibodies, thrombophilia, hormones, prevalence, therapeutics, thrombosis | Int J Transgend Health | 2025 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map